Advertisement

Skin Cancer pp 99-140 | Cite as

Melanoma

  • Philip J. Cohen
  • W. Clark Lambert
  • George J. Hill
  • Robert A. Schwartz

Abstract

The earliest description of melanoma is generally attributed to Hippocrates in the 5th century B.C. The disease has also been noted in several Inca mummies of comparable antiquity (1). The term melanoma was first proposed by Carswell (2) in 1838. As late as the 1950s, however, this disease was known by numerous designations, including melanosarcoma, melanocarcinoma, and nevocarcinoma (3, 4). It is now well understood that this malignancy of the pigment-producing cell arises from neural crest-derived tissue. During early gestation, melanocytes undergo migration from the neural crest to the skin and mucous membranes, uveal tract, and meninges, so that they normally appear in the epidermis, hair bulb, leptomeninges, and retina. Most melanomas occur in the skin.

Keywords

Melanocytic Nevus Amelanotic Melanoma Nodular Melanoma Superficial Spreading Melanoma Vertical Growth Phase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Urteaga O, Pack GT: On the antiquity of melanoma. Cancer 1966; 19:607–610.PubMedCrossRefGoogle Scholar
  2. 2.
    Carswell R: Pathological Anatomy: Part 9. Melanoma. London, Longman, 1838.Google Scholar
  3. 3.
    Driver JR, MacVicar DN: Cutaneous melanomas: A clinical study of sixty cases. JAMA 1943; 131: 413–420.Google Scholar
  4. 4.
    Becker SW: Pitfalls in the diagnosis and treatment of melanoma. Arch Dermatol Syphilol 1954; 69: 11–30.Google Scholar
  5. 5.
    Guillan RA, Zelman S: The incidence and probable origin of melanin in the prostate. J Urol 1970; 104:151–153.PubMedGoogle Scholar
  6. 6.
    Morishita S, Onomura T, Yamamoto S, Nakashima Y: Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) with unusual roentgenologic findings. Clin Orthop 1987; 216: 276–279.PubMedGoogle Scholar
  7. 7.
    Murphy MN, Lorimer SM, Glennon PE: Metastatic melanoma of the gallbladder: A case report and review of the literature. J Surg Oncol 1987; 34:68–72.PubMedCrossRefGoogle Scholar
  8. 8.
    Carstens PHB, Ghazi C, Carnighan RH, Brewer MS: Primary malignant melanoma of the common bile duct. Hum Pathol 1986; 17:1282–1285.PubMedCrossRefGoogle Scholar
  9. 9.
    Alghanem AA, Mehan J, Hassan AA: Primary malignant melanoma of the lung. J Surg Oncol 1987; 34:109–112.PubMedCrossRefGoogle Scholar
  10. 10.
    Stoll DB, Ruschak P, Kauh Y, et al: Lentigo maligna in a woman with oculocutaneous albinism. Arch Dermatol 1981; 117:360–361.PubMedCrossRefGoogle Scholar
  11. 11.
    Wood C, Graham D, Willsen J, Strefling A: Albinism and amelanotic melanoma. Arch Dermatol 1982; 118:283–284.PubMedCrossRefGoogle Scholar
  12. 12.
    Silverberg E, Lubera J: Cancer statistics, 1988. CA 1988; 38:5–22.PubMedGoogle Scholar
  13. 13.
    Cutler SJ, Young JL Jr: Third national cancer survey: Incidence data. Natl Cancer Inst Monogr 1975; 41:20–25.Google Scholar
  14. 14.
    Horm JW, Asire AJ, Young JL Jr, Pollack ES: SEER Program: Cancer Incidence and Mortality in the United States 1973–1981. US Dept of Health and Human Services publication No. (NIH) 85–1837. Bethesda, MD, National Cancer Institute, Division of Cancer Prevention and Control, 1984.Google Scholar
  15. 15.
    McCarthy WH, Martyn AL, Roberts G, Dobson AJ: Melanoma in New South Wales 1970–1976: Confirmation of increased incidence. Med J Aust 1980; 2:137–140.PubMedGoogle Scholar
  16. 16.
    Balch CM, Soong SJ, Milton GW, et al: Changing trends in cutaneous melanoma over a quarter century in Alabama, USA, and New South Wales, Australia, Cancer 1983; 52:1748–1753.PubMedCrossRefGoogle Scholar
  17. 17.
    El wood JM, Lee JAH: Recent data on the epidemiology of malignant melanoma. Semin Oncol 1975; 2:149–154.Google Scholar
  18. 18.
    Cosman B, Heddle SB, Crickelair GF: The increasing incidence of melanoma. Plast Reconstr Surg 1976; 57:50–56.PubMedCrossRefGoogle Scholar
  19. 19.
    Lee JAH: The trend of mortality from primary malignant tumors of skin. J Invest Dermatol 1972; 59:445–448.PubMedCrossRefGoogle Scholar
  20. 20.
    Hakulinen T, Andersen AA, Malker B, et al: Trends in cancer incidence in the Nordic countries: A collaborative study of the five Nordic cancer registries. Acta Pathol Microbiol Scand 1986; 94 (Section A, Suppl 288):78–81.Google Scholar
  21. 21.
    English DR, Heenan PJ, Holman CDJ, et al: Melanoma in Western Australia 1975–76 to 1980–81: Trends in demographic and pathological characteristics. Int J Cancer 1986; 37:209–215.PubMedCrossRefGoogle Scholar
  22. 22.
    Teppo L, Pakkanen M, Hakulinen T: Sunlight as a risk factor of malignant melanoma of the skin. Cancer 1978; 41:2018–2027.PubMedCrossRefGoogle Scholar
  23. 23.
    Swerdlow AJ: Incidence of malignant melanoma of the skin in England and Wales and its relationship to sunshine. Br Med J 1979; 2:1324–1327.PubMedCrossRefGoogle Scholar
  24. 24.
    Hinds MW, Kolonel LM: Malignant melanoma of the skin in Hawaii, 1960–1977. Cancer 1980; 45:811–817.PubMedCrossRefGoogle Scholar
  25. 25.
    Holman CDJ, Armstrong BK: Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 1984; 72:257–266.PubMedGoogle Scholar
  26. 26.
    Dubin N, Moseson M, Pasternack BS: Epidemiology of malignant melanoma: Pigmentary traits, ultraviolet radiation, and the identification of high-risk populations. Recent Results Cancer Res 1986; 102:56–75.PubMedGoogle Scholar
  27. 27.
    Swerdlow AJ, English J, MacKie RM, et al: Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J 1986; 292:1555–1559.CrossRefGoogle Scholar
  28. 28.
    Holly EA, Kelly JW, Shpall SN, Chiu SH: Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987; 17:459–468.PubMedCrossRefGoogle Scholar
  29. 29.
    Green A, MacLennan R, Siskind V: Common acquired naevi and the risk of malignant melanoma. Int J Cancer 1985; 35:297–300.PubMedCrossRefGoogle Scholar
  30. 30.
    Rampen FHJ, van der Meeren HLM, Boezeman JBM: Frequency of moles as a key to melanoma incidence? J Am Acad Dermatol 1986; 15:1200–1203.PubMedCrossRefGoogle Scholar
  31. 31.
    Kopf AW, Gold RS, Rogers GS, et al: Relationship of lumbosacral nevocytic nevi to sun exposure in dysplastic nevus syndrome. Arch Dermatol 1986; 122:1003–1006.PubMedCrossRefGoogle Scholar
  32. 32.
    Viola MV, Houghton A, Munster EW: Solar cycles and malignant melanoma. Med Hypoth 1979; 5:153–160.CrossRefGoogle Scholar
  33. 33.
    Sbano E, Andreassi L, Fimiani M, et al: DNA-repair after UV irradiation in skin fibroblasts from patients with actinic keratosis. Arch Dermatol Res 1978; 262:55–61.PubMedCrossRefGoogle Scholar
  34. 34.
    Abo-Darub JM, Mackie R, Pitts JD: DNA repair deficiency in lymphocytes from patients with actinic keratosis. Bull Cancer 1978; 65:357–362.PubMedGoogle Scholar
  35. 35.
    Lambert WC, Lambert MW: Co-recessive inheritance: A model for DNA repair, genetic disease and carcinogenesis. Mutat Res 1985; 145:227–234.PubMedGoogle Scholar
  36. 36.
    Elwood JM, Gallagher RP, Worth AJ, et al: Etiological differences between subtypes of cutaneous malignant melanoma: Western Canada melanoma study. J Natl Cancer Inst 1987; 78:37–44.PubMedGoogle Scholar
  37. 37.
    Tucker MA, Shields JA, Hartge P, et al: Sunlight exposure as risk factor for intraocular melanoma. N Engl J Med 1985; 313:789–792.PubMedCrossRefGoogle Scholar
  38. 38.
    Kripke ML: Immunology and photocarcinogenesis. J Am Acad Dermatol 1986; 14:149–155.PubMedCrossRefGoogle Scholar
  39. 39.
    Reintgen DS, McCarty KM Jr, Cox E, Seigler HF: Malignant melanoma in black American and white American populations: A comparative review. JAMA 1982; 248:1856–1859.PubMedCrossRefGoogle Scholar
  40. 40.
    Collins RJ: Melanoma in the Chinese of Hong Kong: Emphasis on volar and subungual sites. Cancer 1984; 54:1482–1488.PubMedCrossRefGoogle Scholar
  41. 41.
    Isaacson C, Spector I: Malignant melanomas in the Eur-African-Malay population of South Africa. Am J Dermatopathol 1987; 9:109–110.PubMedCrossRefGoogle Scholar
  42. 42.
    Holman CD J, Armstrong BK, Heenan PJ, et al: The causes of malignant melanoma: Results from the West Australian Lions Melanoma Research Project. Recent Results Cancer Res 1986; 102:18–37.PubMedGoogle Scholar
  43. 43.
    Elwood JM: Could melanoma be caused by fluorescent light? A review of relevant epidemiology. Recent Results Cancer Res 1986; 102:127–136.PubMedGoogle Scholar
  44. 44.
    Clark WH Jr, From L, Bernardino EA, Mihm MC: The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969; 29:705–726.PubMedGoogle Scholar
  45. 45.
    McGovern VJ: The classification of melanoma and its relationship with prognosis. Pathology 1970; 2:85–98.PubMedCrossRefGoogle Scholar
  46. 46.
    McGovern VJ, Cochran AJ, van der Esch EP, et al: The classification of malignant melanoma, its histological reporting and registration: A revision of the 1972 Sydney classification. Pathology 1986; 18:12–21.PubMedCrossRefGoogle Scholar
  47. 47.
    Clark WH Jr, Elder DE, Van Horn M: The biologic forms of malignant melanoma. Hum Pathol 1986; 17:443–450.PubMedCrossRefGoogle Scholar
  48. 48.
    Ackerman AB, David KM: A unifying concept of malignant melanoma: Biologic aspects. Hum Pathol 1986; 17:438–440.PubMedCrossRefGoogle Scholar
  49. 49.
    Seiji M, Takematsu H, Hosokawa M, et al: Acral melanoma in Japan. J Invest Dermatol 1983; 80:56s-60s.PubMedCrossRefGoogle Scholar
  50. 50.
    Krementz ET, Sutherland CM, Carter RD, Ryan RF: Malignant melanoma in the American black. Ann Surg 1976; 183:533–542.PubMedCrossRefGoogle Scholar
  51. 51.
    Mihm MC Jr, Lopansri S: A review of the classification of malignant melanoma. J Dermatol (Tokyo) 1979; 6:131–142.PubMedGoogle Scholar
  52. 52.
    Savin JA, Hardie RA: Proprietary depigmenting cream used wrongly for lentigo maligna. Br Med J 1981; 282:1666–1667.CrossRefGoogle Scholar
  53. 53.
    Weinstock MA, Sober AJ: The risk of progression of lentigo maligna to lentigo maligna melanoma. Br J Dermatol 1987; 116:303–310.PubMedCrossRefGoogle Scholar
  54. 54.
    Rosenberg L, Goldstein J, Ben-Yakar Y, Mahler D: The pedunculated malignant melanoma: A misunderstood and neglected variant. J Dermatol Surg Oncol 1981; 7:123–126.PubMedGoogle Scholar
  55. 55.
    Niven J, Lubin J: Pedunculated malignant melanoma. Arch Dermatol 1975; 111:755–756.PubMedCrossRefGoogle Scholar
  56. 56.
    Shapiro L, Bodian EU: Malignant melanoma in the form of pedunculated papules. Arch Dermatol 1969; 99:49–50.PubMedCrossRefGoogle Scholar
  57. 57.
    Ben-Hur N, Golan J, Rosenberg L, Baruchin A: Pedunculated malignant melanoma. J Dermatol Surg Oncol 1981; 7:127–129.PubMedGoogle Scholar
  58. 58.
    Beardmore GL: Primary cutaneous polypoidal non-stageable melanomas in Queensland. Aust J Dermatol 1977; 18:73–76.CrossRefGoogle Scholar
  59. 59.
    Reed KM, Bronstein BR, Mihm MC Jr, Sober AJ: Prognosis for polypoidal melanoma is determined by primary tumor thickness. Cancer 1986; 57:1201–1203.PubMedCrossRefGoogle Scholar
  60. 60.
    Mihm MC Jr, Clark WH Jr, Reed RJ: The clinical diagnosis of malignant melanoma. Semin Oncol 1975; 2:105–118.PubMedGoogle Scholar
  61. 61.
    Arrington JH III, Reed RJ, Ichinose H, Krementz ET: Plantar lentiginous melanoma: A distinctive variant of human cutaneous malignant melanoma. Am J Surg Pathol 1977; 1:131–143.PubMedCrossRefGoogle Scholar
  62. 62.
    Seiji M, Mihm MC Jr, Sober AJ, et al: Malignant melanoma of the palmar-plantar-subungual-mucosal type: Clinical and histopathological features, in Klaus SN (Ed): Pigment Cell. Basel, Karger, 1979, vol 5, pp 95–104.Google Scholar
  63. 63.
    Miura S, Jimbow K: Clinical characteristics of subungual melanomas in Japan: Case report and a questionnaire survey of 108 cases. J Dermatol (Tokyo) 1985; 12:393–402.PubMedCrossRefGoogle Scholar
  64. 64.
    Feibleman CE, Stoll H, Maize JC: Melanomas of the palm, sole, and nailbed: A clinicopathologic study. Cancer 1980; 46:2492–2504.PubMedCrossRefGoogle Scholar
  65. 65.
    Milton GW, Shaw HM, McCarthy WH: Subungual malignant melanoma: A disease entity separate from other forms of cutaneous melanoma. Aust J Dermatol 1985; 26:61–64.CrossRefGoogle Scholar
  66. 66.
    Jimbow K, Ikeda S, Takahashi H, et al: Biological behavior and natural course of acral malignant melanoma: Clinical and histologic features and prognosis of palmoplanar, subungual, and other acral malignant melanomas. Am J Dermatopathol 1984; 6 (Suppl 1):43–53.PubMedGoogle Scholar
  67. 67.
    Krementz ET, Reed RJ, Coleman WP III, et al: Acral lentiginous melanoma: A clinicopathologic entity. Ann Surg 1982; 195:632–645.PubMedCrossRefGoogle Scholar
  68. 68.
    Fleming ID: Barnawell JR, Burlison PE, Rankin JS: Skin cancer in black patients. Cancer 1975; 35:600–605.PubMedCrossRefGoogle Scholar
  69. 69.
    Klausner JM, Inbar M, Gutman M, et al: Nail-bed melanoma. J Surg Oncol 1987; 34:208–210.PubMedCrossRefGoogle Scholar
  70. 70.
    Kato T, Tanita Y, Takematsu H, Tagami H: Pigmented freckles on the sole as acral lentiginous melanoma in situ. J Dermatol (Tokyo) 1985; 12: 263–266.PubMedGoogle Scholar
  71. 71.
    Patterson RH, Helwig EB: Subungual malignant melanoma: A clinical-pathologic study. Cancer 1980; 46:2074–2087.PubMedCrossRefGoogle Scholar
  72. 72.
    Hutchinson J: Melanosis often not black: Melanotic whitlow. Br Med J 1886; 1:491.Google Scholar
  73. 73.
    Mikhail GR: Hutchinson’s sign. J Surg Oncol 1986; 12:519–521.Google Scholar
  74. 74.
    Colver GB, Millard PR, Dawber RPR: Atypical malignant melanoma of the nail apparatus. Br J Dermatol 1986; 114:389–392.PubMedCrossRefGoogle Scholar
  75. 75.
    Nakamura S, Nishihara K, Hoshi K, et al: Subungual amelanotic malignant melanoma. J Dermatol (Tokyo) 1985; 12:530–533.PubMedGoogle Scholar
  76. 76.
    Scotto J, Fraumeni JF Jr, Lee JAH: Melanomas of the eye and other noncutaneous sites: Epidemiologic aspects. J Natl Cancer Inst 1976; 56:489–491.PubMedGoogle Scholar
  77. 77.
    Kato T, Takematsu H, Tomita Y, et al: Malignant melanoma of mucous membranes: A clinicopatho-logic study of 13 cases in Japanese patients. Arch Dermatol 1987; 123:216–220.PubMedCrossRefGoogle Scholar
  78. 78.
    Didolkar MS, Elias EG, Barber NA, Moore RH: Biologic behavior of ocular malignant melanoma and comparison with melanoma of the head and neck. Am J Surg 1980; 140:522–526.PubMedCrossRefGoogle Scholar
  79. 79.
    Jakobiec F: Conjunctival melanoma: Unfinished business. Arch Ophthalmol 1980; 98:1378–1384.PubMedGoogle Scholar
  80. 80.
    Friedman RJ, Rodriguez-Sains R, Jakobiec F: Conjunctival malignant melanoma in association with sporadic dysplastic nevus syndrome. J Dermatol Surg Oncol 1987; 13:31–34.PubMedGoogle Scholar
  81. 81.
    Roper JP, Jones T, Common JDA: Desmoplastic malignant melanoma masquerading as chalazion. Br J Ophthalmol 1986; 70:907–910.PubMedCrossRefGoogle Scholar
  82. 82.
    Folberg R, McLean IW: Primary acquired melanosis and melanoma of the conjunctiva: Terminology, classification, and biologic behavior. Hum Pathol 1986; 17:652–654.PubMedCrossRefGoogle Scholar
  83. 83.
    Jeffrey IJM, Lucas DR, McEwan C, Lee WR: Malignant melanoma of the conjunctiva. Histopathology 1986; 10:363–378.PubMedCrossRefGoogle Scholar
  84. 84.
    Oldbring J, Mikulowski P: Malignant melanoma of the penis and male urethra: Report of nine cases and review of the literature. Cancer 1987; 59: 581–587.PubMedCrossRefGoogle Scholar
  85. 85.
    Jorda E, Verdeger JM, Moragon M, et al: Desmoplastic melanoma of the penis. J Am Acad Dermatol 1987; 16:619.PubMedCrossRefGoogle Scholar
  86. 86.
    Forrer JA, Sugrue DL: Malignant melanoma of prepuce: Case report. Genitourin Med 1986; 62: 399–401.PubMedGoogle Scholar
  87. 87.
    Wanebo HJ, Woodruff JM, Farr GH, Quan SH: Anorectal melanoma. Cancer 1981; 47:1891–1900.PubMedCrossRefGoogle Scholar
  88. 88.
    Rhodes AR, Wood WC, Sober AJ, Mihm MC Jr: Nonepidermal origin of malignant melanoma associated with a giant congenital nevocellular nevus. Plast Reconstr Surg 1981; 67:782–790.PubMedCrossRefGoogle Scholar
  89. 89.
    Rubinstein N, Kopolovic J, Wexler MR, Peled IJ: Malignant blue nevus. J Dermatol Surg Oncol 1985; 11:921–923.PubMedGoogle Scholar
  90. 90.
    Hernandez FJ: Malignant blue nevus: A light and electron microscopic study. Arch Dermatol 1973; 107:741–744.PubMedCrossRefGoogle Scholar
  91. 91.
    Merkow LP, Burt RC, Hayeslip DW, et al: A cellular and malignant blue nevus: A light and electron microscopic study. Cancer 1969; 24:888–896.PubMedCrossRefGoogle Scholar
  92. 92.
    Kwittken J, Negri L: Malignant blue nevus: Case report of a negro woman. Arch Dermatol 1966; 94:64–69.PubMedCrossRefGoogle Scholar
  93. 93.
    Dorsey CS, Montgomery H: Blue nevus and its distinction from mongolian spot and the nevus of Ota. J Invest Dermatol 1954; 22:225–236.PubMedCrossRefGoogle Scholar
  94. 94.
    Lambert WC, Brodkin RH: Nodal and subcutaneous cellular blue nevi: A pseudometastasizing pseudomelanoma. Arch Dermatol 1984; 120:367–370.PubMedCrossRefGoogle Scholar
  95. 95.
    Kroon S, Clemmensen OJ, Hastrup N: Incidence of congenital melanocytic nevi in newborn babies in Denmark. J Am Acad Dermatol 1987; 17:422–426.PubMedCrossRefGoogle Scholar
  96. 96.
    Alper J, Holmes LB, Mihm MC Jr: Birthmarks with serious medical significance: Nevocellular nevi, sebaceous nevi, and multiple café au lait spots. J Pediatr 1979; 95:696–700.PubMedCrossRefGoogle Scholar
  97. 97.
    Walton RG, Jacobs AH, Cox AJ: Pigmented lesions in newborn infants. Br J Dermatol 1976; 95:389–396.PubMedCrossRefGoogle Scholar
  98. 98.
    Kopf AW, Bart RS, Hennessey P: Congenital melanocytic nevi and malignant melanomas. J Am Acad Dermatol 1979; 1:123–130.PubMedCrossRefGoogle Scholar
  99. 99.
    Kaplan EN: The risk of malignancy in large congenital nevi. Plast Reconstr Surg 1974; 53:421–428.PubMedCrossRefGoogle Scholar
  100. 100.
    Lorentzen M, Pers M, Bretteville-Jensen G: The incidence of malignant transformation in giant pigmented nevi. Scand J Plast Reconstr Surg 1977; 11:163–167.PubMedCrossRefGoogle Scholar
  101. 101.
    Keipert JA: Giant pigmented naevus: The frequency of malignant change and indications for treatment in prepubertal children. Aust J Dermatol 1985; 26:81–85.CrossRefGoogle Scholar
  102. 102.
    Alper JC: Congenital nevi: The controversy rages on. Arch Dermatol 1985; 121:734–735.PubMedCrossRefGoogle Scholar
  103. 103.
    Illig L, Weidner F, Hundeiker M, et al: Congenital nevi ≤ 10 cm as precursors to melanoma: 52 cases, a review, and a new conception. Arch Dermatol 1985; 121:1274–1281.PubMedCrossRefGoogle Scholar
  104. 104.
    Reed WB, Becker SW Sr, Becker SW Jr, Nickel WR: Giant pigmented nevi, melanoma, and leptomeningeal melanocytosis. Arch Dermatol 1965; 91:100–119.PubMedCrossRefGoogle Scholar
  105. 105.
    Wiltz H, Kollmer WL, Rauscher GE, et al: Excision of large congenital melanocytic nevus facilitated by the use of the tissue expander. J Surg Oncol, in press.Google Scholar
  106. 106.
    Rhodes AR: Pigmented birthmarks and precursor melanocytic lesions of cutaneous melanoma identifiable in childhood. Pediatr Clin North Am 1983; 30:435–463.PubMedGoogle Scholar
  107. 107.
    Rhodes AR, Sober AJ, Day CL, et al: The malignant potential of small congenital nevocellular nevi: An estimate of association based on a histologic study of 234 primary cutaneous melanomas. J Am Acad Dermatol 1982; 6:230–241.PubMedCrossRefGoogle Scholar
  108. 108.
    Lanier VC Jr, Pickrell KL, Georgiade NG: Congenital giant nevi: Clinical and pathological considerations. Plast Reconstr Surg 1976; 58:48–54.PubMedCrossRefGoogle Scholar
  109. 109.
    Rhodes AR, Melski JW: Small congenital nevocellular nevi and the risk of cutaneous melanoma. J Pediatr 1982; 100:219–224.PubMedCrossRefGoogle Scholar
  110. 110.
    Solomon LM: The management of congenital melanocytic nevi. Arch Dermatol 1980; 116:1017.PubMedCrossRefGoogle Scholar
  111. 111.
    Rhodes AR: The risk of malignant melanoma arising in congenital melanocytic nevi: An argument against the assignment of risk based on size alone. Am J Dermatopathol 1984; 6 (Suppl 1): 184–188.PubMedGoogle Scholar
  112. 112.
    Skov-Jensen T, Hastrup J, Lambrethsen E: Malignant melanoma in children. Cancer 1966; 19: 620–626.PubMedCrossRefGoogle Scholar
  113. 113.
    Schneiderman H, Wu AY, Campbell WA, et al: Congenital melanoma with multiple prenatal metastases. Cancer 1987; 60:1371–1377.PubMedCrossRefGoogle Scholar
  114. 114.
    Fox H, Emery JL, Goodbody RA, Yates PO: Neuro-cutaneous melanosis. Arch Dis Child 1964; 39:508–516.PubMedCrossRefGoogle Scholar
  115. 115.
    Pappenheim E, Bhattacharji SE: Primary melanoma of the central nervous system: Clinical-pathological report of a case, with survey and discussion of the literature. Arch Neurol 1962; 7:101–113.PubMedGoogle Scholar
  116. 116.
    Yu HS, Tsaur KC, Chien CH, et al: Neurocutaneous melanosis: Electron microscopic comparison of the pigmented melanocytic nevi of skin and meningeal melanosis. J Dermatol (Tokyo) 1985; 12:267–276.PubMedGoogle Scholar
  117. 117.
    Enriquez R, Egbert B, Bullock J: Primary malignant melanoma of the central nervous system. Arch Pathol 1973; 95:392–395.PubMedGoogle Scholar
  118. 118.
    Bader JL, Strickman NA, Li FP, Green DM, Olstead PM: Childhood malignant melanoma: Incidence and etiology. Am J Pediatr Hematol Oncol 1985; 7:341–345.PubMedGoogle Scholar
  119. 119.
    Boddie AW Jr, Smith JL Jr, McBride CM: Malignant melanoma in children and young adults: Effect of diagnostic criteria on staging and end results. South Med J 1978; 71:1074–1078.PubMedCrossRefGoogle Scholar
  120. 120.
    Peters MS, Goellner JR: Spitz naevi and malignant melanomas of childhood and adolescence. Histopathology 1986; 10:1289–1302.PubMedCrossRefGoogle Scholar
  121. 121.
    Anderson DE: Clinical characteristics of the genetic variety of cutaneous melanoma in man. Cancer 1971; 28:721–725.PubMedCrossRefGoogle Scholar
  122. 122.
    Schwartz RA, Klein E: Ultraviolet light-induced carcinogenesis, in Holland JF, Frei E III (Eds): Cancer Medicine, 2nd ed. Philadelphia, Lea & Febiger, 1982, pp 109–119.Google Scholar
  123. 123.
    Luande J, Henschke CI, Mohammed N: The Tanzanian human albino skin: Natural history. Cancer 1985; 55:1823–1828.PubMedCrossRefGoogle Scholar
  124. 124.
    Clark WH Jr: A classification of malignant melanoma in man correlated with histogenesis and biologic behavior, in Montagna W, Hu F (Eds): Advances in Biology of Skin. Vol 8: The Pigment System. London, Pergamon Press, 1967, pp 621–647.Google Scholar
  125. 125.
    Kuehnl-Petzoldt C, Beŗger H, Wiebelt H: Verrucous-keratotic variations of malignant melanoma: A clinicopathological study. Am J Dermatopathol 1982; 4:403–410.PubMedGoogle Scholar
  126. 126.
    Krebs JA, Roenigk HH, Deodhar SD, Barna B: Halo nevus: Competent surveillance of potential melanoma? Cleve Clin Q 1976; 43:11–15.PubMedGoogle Scholar
  127. 127.
    Giuliano AE, Cochran AJ, Morton DL: Melanoma from an unknown primary site and amelanotic melanoma. Semin Oncol 1982; 9:442–447.PubMedGoogle Scholar
  128. 128.
    Huvos AG, Shah JP, Goldsmith HS: A clinicopathologic study of amelanotic melanoma. Surg Gynecol Obstet 1972; 135:917–920.PubMedGoogle Scholar
  129. 129.
    Borkovic SP, Schwartz RA: Amelanotic lentigo maligna melanoma manifesting as a dermatitislike plaque. Arch Dermatol 1983; 119:423–425.PubMedCrossRefGoogle Scholar
  130. 130.
    Su WPD, Bradley RR: Amelanotic lentigo maligna. Arch Dermatol 1980; 116:82–83.PubMedCrossRefGoogle Scholar
  131. 131.
    Goldberg DJ: Amelanotic melanoma presenting as Bowen’s disease. J Dermatol Surg Oncol 1983; 9:902–904.PubMedGoogle Scholar
  132. 132.
    Pechman KJ, Bailin P: Recurrent amelanotic lentigo maligna melanoma: A case report. Cleve Clin Q 1983; 50:173–175.PubMedGoogle Scholar
  133. 133.
    McBurney EI, Herron CB: Melanoma mimicking plantar wart. J Am Acad Dermatol 1979; 1:144–146.PubMedCrossRefGoogle Scholar
  134. 134.
    Leppard B, Sanderson KV, Behan F: Subungual malignant melanoma: Difficulty in diagnosis. Br Med J 1974; 1:310–312.PubMedCrossRefGoogle Scholar
  135. 135.
    Das Gupta TK, Brasfield RD, Paglia MA: Primary melanomas in unusual sites. Surg Gynecol Obstet 1969; 128:841–848.Google Scholar
  136. 136.
    Moseley HS, Giuliano AE, Storm FK, et al: Multiple primary melanoma. Cancer 1979; 43:939–944.PubMedCrossRefGoogle Scholar
  137. 137.
    Beardmore GL, Davis NC: Multiple primary cutaneous melanoma. Arch Dermatol 1975; 111: 603–609.PubMedCrossRefGoogle Scholar
  138. 138.
    Chang P, Knapper WH: Metastatic melanoma of unknown primary. Cancer 1982; 49:1106–1111.PubMedCrossRefGoogle Scholar
  139. 139.
    Das Gupta T, Bowden L: Malignant melanoma of unknown primary origin. Surg Gynecol Obstet 1963; 117:341–345.Google Scholar
  140. 140.
    Baab GH, McBride CM: Malignant melanoma: The patient with an unknown site of primary origin. Arch Surg 1975; 110:896–900.PubMedGoogle Scholar
  141. 141.
    Milton GW, Shaw HM, McCarthy WH: Occult primary malignant melanoma: Factors influencing survival. Br J Surg 1977; 64:805–808.PubMedCrossRefGoogle Scholar
  142. 142.
    Cochran AJ: Malignant melanoma: A review of 10 years’ experience in Glasgow, Scotland. Cancer 1969; 23:1190–1199.PubMedCrossRefGoogle Scholar
  143. 143.
    Guarischi A, Keane TJ, Elhakim T: Metastatic inguinal nodes from an unknown primary neoplasm. Cancer 1987; 59:572–577.PubMedCrossRefGoogle Scholar
  144. 144.
    Smith JL Jr, Stehlin JS Jr: Spontaneous regression of primary malignant melanomas with regional metastases. Cancer 1965; 18:1399–1415.PubMedCrossRefGoogle Scholar
  145. 145.
    Mikhail GR, Gorsulowsky DC: Spontaneous regression of metastatic malignant melanoma. J Dermatol Surg Oncol 1986; 12:497–500.PubMedGoogle Scholar
  146. 146.
    Bulkley GB, Cohen MH, Banks PM, et al: Long-term spontaneous regression of malignant melanoma with visceral metastases. Cancer 1975; 36:485–494.PubMedCrossRefGoogle Scholar
  147. 147.
    Steiner A, Wolf C, Pehamberger H, Wolff K: Late metastases of cutaneous malignant melanoma. Br J Dermatol 1986; 114:737–740.PubMedCrossRefGoogle Scholar
  148. 148.
    Raderman D, Giler S, Rothem A, Ben-Bassat M: Late metastases (beyond ten years) of cutaneous malignant melanoma: Literature review and case report. J Am Acad Dermatol 1986; 15:374–378.PubMedCrossRefGoogle Scholar
  149. 149.
    Koh HK, Sober AJ, Fitzpatrick TB: Late recurrence (beyond ten years) of cutaneous malignant melanoma: Report of two cases and a review of the literature. JAMA 1984; 251:1859–1862.PubMedCrossRefGoogle Scholar
  150. 150.
    Fitzpatrick TB, Montgomery H, Lerner AB: Pathogenesis of generalized dermal pigmentation secondary to malignant melanoma and melanuria. J Invest Dermatol 1954; 22:163–172.CrossRefGoogle Scholar
  151. 151.
    Silberbeig I, Kopf AW, Gumport SL: Diffuse melanosis in malignant melanoma. Arch Dermatol 1968; 97:671–677.CrossRefGoogle Scholar
  152. 152.
    Konrad K, Wolff K: Pathogenesis of diffuse melanosis secondary to malignant melanoma. Br J Dermatol 1974; 91:635–655.PubMedCrossRefGoogle Scholar
  153. 153.
    Sohn N, Gang H, Gumport SL, et al: Generalized melanosis secondary to malignant melanoma: Report of a case with serum and tissue tyrosinase studies. Cancer 1969; 24:897–903.PubMedCrossRefGoogle Scholar
  154. 154.
    Eide J: Pathogenesis of generalized melanosis with melanuria and melanoptysis secondary to malignant melanoma. Histopathology 1981; 5:285–294.PubMedCrossRefGoogle Scholar
  155. 155.
    Duray PH, Ernstoff MS: Dysplastic nevus in histologic contiguity with acquired nonfamilial melanoma: Clinicopathologic experience in a 100-bed hospital. Arch Dermatol 1987; 123:80–84.PubMedCrossRefGoogle Scholar
  156. 156.
    Penneys NS: Microinvasive lentigo maligna melanoma. J Am Acad Dermatol 1987; 17:675–680.PubMedCrossRefGoogle Scholar
  157. 157.
    Cartwright LE, Steinman HK: Malignant papillary mesothelioma of the tunica vaginalis testes: Cutaneous metastases showing pagetoid epidermal invasion. J Am Acad Dermatol 1987; 17:887–890.PubMedCrossRefGoogle Scholar
  158. 158.
    Guldhammer B, Nørgaard T: The differential diagnosis of intraepidermal malignant lesions using immunohistochemistry. Am J Dermatopathol 1986; 8:295–301.PubMedCrossRefGoogle Scholar
  159. 159.
    Caselitz J, Janner M, Breitbach E, et al: Malignant melanomas contain only the vimentin type of intermediate filaments. Virchows Arch [Pathol Anat] 1983; 400:331–344.CrossRefGoogle Scholar
  160. 160.
    Phillips ME, Margolis RJ, Merot Y, et al: The spectrum of minimal deviation melanoma: A clinicopathologic study of 21 cases. Hum Pathol 1986; 17:796–806.PubMedCrossRefGoogle Scholar
  161. 161.
    Lambert WC, Lambert MW, Mesa ML, et al: Melanoacanthoma and related disorders: Simulants of acral-lentiginous (P-P-S-M) melanoma. Int J Dermatol 1987; 26:508–510.PubMedCrossRefGoogle Scholar
  162. 162.
    Rhodes AR, Silverman RA, Harrist TJ, Melski JW: A histologic comparison of congenital and acquired nevomelanocytic nevi. Arch Dermatol 1985; 121: 1266–1273.PubMedCrossRefGoogle Scholar
  163. 163.
    Mark GJ, Mihm MC, Liteplo MG, etal: Congenital melanocytic nevi of the small and garment type. Hum Pathol 1973; 4:395–418.PubMedCrossRefGoogle Scholar
  164. 164.
    Ellis DL, Wheeland RG, Solomon H: Estrogen and progesterone receptors in congenital melanocytic nevi. J Am Acad Dermatol 1985; 12:235–244.PubMedCrossRefGoogle Scholar
  165. 165.
    Fenton DA, Mayou B, Atherton D, Black MM: Histopathology of giant congenital melanocytic naevi: Implications for treatment. Br J Dermatol 1987; 117 (Suppl 32):40.CrossRefGoogle Scholar
  166. 166.
    Weedon D: Borderline melanocytic tumors. J Cutan Pathol 1985; 12:266–270.PubMedCrossRefGoogle Scholar
  167. 167.
    Reed RJ, Leonard DD: Neurotropic melanoma: A variant of desmoplastic melanoma. Am J Surg Pathol 1979; 3:301–311.PubMedCrossRefGoogle Scholar
  168. 168.
    Frolow GR, Shapiro L, Brownstein MH: Desmoplastic malignant melanoma. Arch Dermatol 1975; 111:753–754.PubMedCrossRefGoogle Scholar
  169. 169.
    Magnin PH, Casas JG, Duhm G: Melanoma neurotropo. Med Cutan Ibero Lat Am 1983; 11:247–252.PubMedGoogle Scholar
  170. 170.
    Valensi QJ: Desmoplastic malignant melanoma: A light and electron microscopic study of two cases. Cancer 1979; 43:1148–1155.PubMedCrossRefGoogle Scholar
  171. 171.
    Bryant E, Ronan SG, Felix EL, Manaligod JR: Desmoplastic malignant melanoma: A study by conventional and electron microscopy. Am J Dermatopathol 1982; 4:467–474.PubMedCrossRefGoogle Scholar
  172. 172.
    Warner TFCS, Ford CN, Hafez GR: Neurotropic melanoma of the face invading the maxillary nerve. J Cutan Pathol 1985; 12:520–527.PubMedCrossRefGoogle Scholar
  173. 173.
    Hirano T: Immunohistochemical study of malignant melanoma. Acta Pathol Jpn 1986; 36:733–743.PubMedGoogle Scholar
  174. 174.
    Peters MS, Su WPD: Balloon cell malignant melanoma. J Am Acad Dermatol 1985; 13:351–354.PubMedCrossRefGoogle Scholar
  175. 175.
    Kato T, Demitsu T, Tomita Y, Tagami H: New primary malignant melanoma, epidermotropism and Indian-file arrangement of metastatic tumor cells in a case with intransit metastases of acral type of malignant melanoma. Dermatologica 1986; 173:85–100.CrossRefGoogle Scholar
  176. 176.
    Komberg R, Harris M, Ackerman AB: Epider-motropically metastatic malignant melanoma: Differentiating malignant melanoma metastatic to the epidermis from malignant melanoma primary in the epidermis. Arch Dermatol 1978; 114:67–69.CrossRefGoogle Scholar
  177. 177.
    Spitz S: Melanomas of childhood. Am J Pathol 1948; 24:591–609.PubMedGoogle Scholar
  178. 178.
    Kornberg R, Ackerman AB: Pseudomelanoma: Recurrent melanocytic nevus following partial surgical removal. Arch Dermatol 1975; 111:1588–1590.PubMedCrossRefGoogle Scholar
  179. 179.
    Ronnen M, Sokol MS, Huszar M, et al: Pseudomelanoma following treatment with surgical excision and intralesional triamicinolone acetonide to prevent keloid formation. Int J Dermatol 1986; 25:533–534.PubMedCrossRefGoogle Scholar
  180. 180.
    Tsuchida T, Saxton RE, Irie RF: Gangliosides of human melanoma: GM2 and tumorigenicity. J Natl Cancer Inst 1987; 78:55–60.PubMedGoogle Scholar
  181. 181.
    Imam A, Mitchell MS, Modlin RL, et al: Human monoclonal antibodies that distinguish cutaneous malignant melanomas from benign nevi in fixed tissue sections. J Invest Dermatol 1986; 86:145–148.PubMedCrossRefGoogle Scholar
  182. 182.
    Irie RF, Morton DL: Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2. Proc Natl Acad Sci USA 1986; 83:8694–8698.PubMedCrossRefGoogle Scholar
  183. 183.
    Spitler LE, del Rio M, Khentigan A, et al: Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin. Cancer Res 1987; 47:1717–1723.PubMedGoogle Scholar
  184. 184.
    Cheung NKV, Lazarus H, Miraldi FD, et al: Ganglioside GD2 specific monoclonal antibody 3F8: A phase I study in patients with neuroblastoma and malignant melanoma. J Clin Oncol 1987; 5:1430–1440.PubMedGoogle Scholar
  185. 185.
    Kirkwood JM, Neumann RD, Zoghbi SS, et al: Scintigraphic detection of metastatic melanoma using indium 111/DTPA conjugated anti-gp240 antibody (ZME-018). J Clin Oncol 1987; 5:1247–1255.PubMedGoogle Scholar
  186. 186.
    McMullan FH, Hubener LF: Malignant melanoma: A statistical review of clinical and histological diagnosis. Arch Dermatol 1956; 74:618–619.Google Scholar
  187. 187.
    Swerdlow M: Nevi: A problem of misdiagnosis. Am J Clin Pathol 1952; 22:1054–1060.PubMedGoogle Scholar
  188. 188.
    Kopf AW, Mintzis M, Bart RS: Diagnostic accuracy in malignant melanoma. Arch Dermatol 1975; 111:1291–1292.PubMedCrossRefGoogle Scholar
  189. 189.
    Wetherington GM, Norins AL, Sadove AM: Locally invasive cellular blue nevus of the scalp. Plast Reconstr Surg 1987; 79:114–117.PubMedCrossRefGoogle Scholar
  190. 190.
    Allen AC, Spitz S: Malignant melanoma: A clinicopathologic analysis of the criteria for diagnosis and prognosis. Cancer 1953; 6:1–45.PubMedCrossRefGoogle Scholar
  191. 191.
    Okun MR: Melanoma resembling spindle and epithelioid cell nevus: Report of three cases. Arch Dermatol 1979; 115:1416–1420.PubMedCrossRefGoogle Scholar
  192. 192.
    Schwartz RA, Hill WE, Hansen RC, Fleishman JS: Verrucous malignant melanoma. J Dermatol Surg Oncol 1980; 6:719–724.PubMedGoogle Scholar
  193. 193.
    Fitzpatrick TB, Gilchrest BA: Dimple sign to differentiate benign from malignant pigmented cutaneous lesions. N Engl J Med 1977; 296:1518.PubMedCrossRefGoogle Scholar
  194. 194.
    Goldman L, Gibson SH, Richfield DF: Thrombotic angiokeratoma circumscriptum simulating melanoma. Arch Dermatol 1981; 117:138–139.PubMedCrossRefGoogle Scholar
  195. 195.
    Baran R, Laugier P: Melanonychia induced by topical 5-fluorouracil. Br J Dermatol 1985; 112:621–625.PubMedCrossRefGoogle Scholar
  196. 196.
    McMahon JT, Bergfeld WF: Metallic cutaneous contaminant mimicking malignant melanoma. Cleve Clin Q 1983; 50:177–181.PubMedGoogle Scholar
  197. 197.
    Kadyków M: Mercury granuloma simulating melanoma. Przegl Dermatol 1986; 73:149–151.Google Scholar
  198. 198.
    Balch CM, Soong SJ, Milton GW, et al: A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg 1982; 196:677–684.PubMedCrossRefGoogle Scholar
  199. 199.
    Balch CM, Murad TM, Soong SJ, et al: A multifactorial analysis of melanoma: Prognostic histopathological features comparing Clark’s and Breslow’s staging methods. Ann Surg 1978; 188:732–742.PubMedCrossRefGoogle Scholar
  200. 200.
    Funk W, Schmoeckel C, Holzel D, Braun-Falco O: Prognostic classification of malignant melanoma by clinical criteria. Br J Dermatol 1984; 111: 129–138.PubMedCrossRefGoogle Scholar
  201. 201.
    Cascinelli N, Morabito A, Bufalino R, et al: Prognosis of stage I melanoma of the skin. Int J Cancer 1980; 26:733–739.CrossRefGoogle Scholar
  202. 202.
    Schmoeckel C, Braun-Falco O: Prognostic index in malignant melanoma. Arch Dermatol 1978; 114: 871–873.PubMedCrossRefGoogle Scholar
  203. 203.
    Eldh J, Boeryd B, Peterson LE: Prognostic factors in cutaneous malignant melanoma in stage I: A clinical, morphological and multivariate analysis. Scand J Plast Reconstr Surg 1978; 12:243–255.PubMedCrossRefGoogle Scholar
  204. 204.
    Rogers GS, Kopf AW, Rigel DS, et al: Effect of anatomical location on prognosis in patients with clinical stage I melanoma. Arch Dermatol 1983; 119:644–649.PubMedCrossRefGoogle Scholar
  205. 205.
    Larsen TE, Little JH, Orell SR, Prade M: International pathologists congruence survey on quantitation of malignant melanoma. Pathology 1980; 12:245–253.PubMedCrossRefGoogle Scholar
  206. 206.
    Day CL Jr, Sober AJ, Kopf AW, et al: A prognostic model for clinical stage I melanoma of the upper extremity: The importance of anatomical subsites in predicting recurrent disease. Ann Surg 1981; 193:436–440.PubMedCrossRefGoogle Scholar
  207. 207.
    Day CL Jr, Sober AJ, Kopf AW, et al: A prognostic model for clinical stage I melanoma of the trunk: Location near the midline is not an independent risk factor for recurrent disease. Am J Surg 1981; 142:247–251.PubMedCrossRefGoogle Scholar
  208. 208.
    Day CL Jr, Mihm MC Jr, Sober AJ, et al: Prognostic factors for melanoma patients with lesions 0.76–1.69 mm in thickness: An appraisal of “thin” level IV lesions. Ann Surg 1982; 195:30–34.PubMedCrossRefGoogle Scholar
  209. 209.
    Day CL Jr, Mihm MC Jr, Lew RA, et al: Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51–3.99 mm). Ann Surg 1982; 195:35–43.PubMedCrossRefGoogle Scholar
  210. 210.
    Huvos AG, Mike V, Donnellan MJ, et al: Prognostic factors in cutaneous melanoma of the head and neck. Am J Pathol 1973; 71:33–48.PubMedGoogle Scholar
  211. 211.
    Kopf AW, Welkovich B, Frankel RE, et al: Thickness of malignant melanoma: Global analysis of related factors. J Dermatol Surg Oncol 1987; 13:345–420.PubMedGoogle Scholar
  212. 212.
    Kopf AW, Gross DF, Rogers GS, et al: Prognostic index for malignant melanoma. Cancer 1987; 59:1236–1241.PubMedCrossRefGoogle Scholar
  213. 213.
    Kuehnl-Petzold C, Wiebelt H, Berger H, Wagner G: A proposal for staging malignant melanoma. Arch Dermatol Res 1983; 275:255–256.PubMedGoogle Scholar
  214. 214.
    Fortner JG, Woodruff J, Schottenfeld D, MacLean B: Biostatistical basis of elective node dissection for malignant melanoma. Ann Surg 1977; 186: 101–103.PubMedCrossRefGoogle Scholar
  215. 215.
    Karakousis CP, Seddiq MK, Moore R: Prognostic value of lymph node dissection in malignant melanoma. Arch Surg 1980; 115:719–722.PubMedGoogle Scholar
  216. 216.
    Cohen MH, Ketcham AS, Felix EL, et al: Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg 1977; 186:635–642.PubMedCrossRefGoogle Scholar
  217. 217.
    Balch CM, Soong SJ, Murad TM, et al: A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg 1981; 193:377–388.PubMedCrossRefGoogle Scholar
  218. 218.
    Doss LL, Padilla RS, Hladik WB: Technetium antimony sulfur colloid scintiscan in selective lymph node dissection for malignant melanoma. J Dermatol Surg Oncol 1986; 12:1280–1284.PubMedGoogle Scholar
  219. 219.
    Murray JL, Rosenblum MG, Lamki L, et al: Clinical parameters related to optimal tumor localization of Indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018. J Nucl Med 1987; 28:25–33.PubMedGoogle Scholar
  220. 220.
    Beahrs OH, Myers MH: Manual for Staging of Cancer. American Joint Committee on Cancer, Philadelphia, JB Lippincott, 1983, p 117.Google Scholar
  221. 221.
    Clark WH Jr, Ainsworth AM, Bernardino EA, et al: The developmental biology of primary human malignant melanomas. Semin Oncol 1975; 2:83–103.PubMedGoogle Scholar
  222. 222.
    Breslow A: Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172:902–908.PubMedCrossRefGoogle Scholar
  223. 223.
    Blois MS, Sagebiel RW, Abarbanel RM, et al: Malignant melanoma of the skin: The association of tumor depth and type, and patient sex, age, and site with survival. Cancer 1983; 52:1330–1341.PubMedCrossRefGoogle Scholar
  224. 224.
    Wanebo HJ, Fortner JG, Woodruff J, et al: Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow). Ann Surg 1975; 182:302–315.PubMedCrossRefGoogle Scholar
  225. 225.
    Wanebo HJ, Woodruff J, Fortner JG: Malignant melanoma of the extremities: A clinicopathologic study using levels of invasion (microstage). Cancer 1975; 35:666–676.PubMedCrossRefGoogle Scholar
  226. 226.
    Breslow A: Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma. Ann Surg 1975; 182:572–575.PubMedCrossRefGoogle Scholar
  227. 227.
    Balch CM, Murad TM, Soong SJ, et al: Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer 1979; 43:883–888.PubMedCrossRefGoogle Scholar
  228. 228.
    Prade M, Sancho-Garnier H, Cesarini JP, Cochran A: Difficulties encountered in the application of Clark classification and the Breslow thickness measurement in cutaneous malignant melanoma. Int J Cancer 1980; 26:159–163.PubMedCrossRefGoogle Scholar
  229. 229.
    Day CL Jr, Sober AJ, Kopf AW, et al: A prognostic model for clinical stage I melanoma of the lower extremity. Surgery 1981; 89:599–603.PubMedGoogle Scholar
  230. 230.
    Day CL Jr, Lew RA, Mihm MC, et al: A multivariate analysis of prognostic factors for melanoma patients with lesions ≥3.65 mm in thickness: The importance of revealing alternative Cox models. Ann Surg 1982; 195:44–49.PubMedCrossRefGoogle Scholar
  231. 231.
    Day CL Jr, Lew RA, Mihm MC Jr, et al: The natural break points for primary-tumor thickness in clinical stage I melanoma. N Engl J Med 1981; 305:1155.PubMedGoogle Scholar
  232. 232.
    McGovern VJ: Spontaneous regression of melanoma. Pathology 1975; 7:91–99.PubMedCrossRefGoogle Scholar
  233. 233.
    Trau H, Rigel DS, Harris MN, et al: Metastases of thin melanomas. Cancer 1983; 51:553–556.PubMedCrossRefGoogle Scholar
  234. 234.
    Gromet MA, Epstein WL, Blois MS: The regressing thin malignant melanoma: A distinctive lesion with metastatic potential. Cancer 1978; 42:2282–2292.PubMedCrossRefGoogle Scholar
  235. 235.
    Naruns PL, Nizze JA, Cochran AJ, et al: Recurrence potential of thin primary melanomas. Cancer 1986; 57:545–548.PubMedCrossRefGoogle Scholar
  236. 236.
    Søndergaard K, Hou-Jensen K: Partial regression in thin primary cutaneous malignant melanomas clinical stage I. Virchows Arch [Pathol Anat] 1985; 408:241–247.CrossRefGoogle Scholar
  237. 237.
    Ronan SG, Eng AM, Briele HA, Shioura NN, Das Gupta TK: Thin malignant melanomas with regression and metastases. Arch Dermatol 1987; 123: 1326–1330.PubMedCrossRefGoogle Scholar
  238. 238.
    Wanebo HJ, Cooper PH, Hagar RW: Thin (≤ 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression. Ann Surg 1985; 201:499–504.PubMedCrossRefGoogle Scholar
  239. 239.
    Kelly JW, Sagebiel RW, Blois MS: Regression in malignant melanoma: A histological feature without independent prognostic significance. Cancer 1885; 56:2287–2291.CrossRefGoogle Scholar
  240. 240.
    Bystryn JC, Rigel D, Friedman RJ, Kopf A: Prognostic significance of hypopigmentation in malignan melanoma. Arch Dermatol 1987; 123:1053–1055.PubMedCrossRefGoogle Scholar
  241. 241.
    Cascinelli N, Vaglini M, Bufalino R, Morabito A: BANS: A cutaneous region with no prognostic significance in patients with melanoma. Cancer 1986; 57:441–444.PubMedCrossRefGoogle Scholar
  242. 242.
    Rogers GS, Kopf AW, Rigel DS, et al: Influence of anatomic location on prognosis of malignant melanoma: Attempt to verify the BANS model. J Am Acad Dermatol 1986; 15:231–237.PubMedCrossRefGoogle Scholar
  243. 243.
    Balch CM, Wilkerson JA, Murad TM, et al: The prognostic significance of ulceration of cutaneous melanoma. Cancer 1980; 45:3012–3017.PubMedCrossRefGoogle Scholar
  244. 244.
    Balch CM, Soong SJ, Murad TM, et al: A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery 1979; 86:343–351.PubMedGoogle Scholar
  245. 245.
    Goldsmith HS, Shah JP, Kim DH: Prognostic significance of lymph node dissection in the treatment of malignant melanoma. Cancer 1970; 26:606–609.PubMedCrossRefGoogle Scholar
  246. 246.
    Gumport SL, Harris MN: Results of regional lymph node dissection for melanoma. Ann Surg 1974; 179:105–108.PubMedCrossRefGoogle Scholar
  247. 247.
    Fortner JG, Das Gupta T, McNeer G: Primary malignant melanoma on the trunk: An analysis of 194 cases. Ann Surg 1965; 161:161–169.PubMedCrossRefGoogle Scholar
  248. 248.
    Guiss LW, MacDonald I: The role of radical regional lymphadenectomy in treatment of melanoma. Am J Surg 1962; 104:135–142.PubMedCrossRefGoogle Scholar
  249. 249.
    Juttner F-M, Smolle J, Popper H, Schneider G: Pitfalls in the diagnosis of pulmonary metastases in malignant melanoma. Dermatologica 1986; 172: 113–115.PubMedCrossRefGoogle Scholar
  250. 250.
    Perry MD, Seigler HF, Johnston WW: Diagnosis of metastatic malignant melanoma by fine needle aspiration biopsy: A clinical and pathologic correlation of 298 cases. J Natl Cancer Inst 1986; 77:1013–1019.PubMedGoogle Scholar
  251. 251.
    Das Gupta TK: Results of treatment of 269 patients with primary cutaneous melanoma: A five-year prospective study. Ann Surg 1977; 186:201–209.CrossRefGoogle Scholar
  252. 252.
    Mundth ED, Guralnick EA, Raker JW: Malignant melanoma: A clinical study of 427 cases. Ann Surg 1965; 162:15–28.PubMedCrossRefGoogle Scholar
  253. 253.
    Day CL Jr, Sober AJ, Lew RA, et al: Malignant melanoma patients with positive nodes and relatively good prognoses: Microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes. Cancer 1981; 47:955–962.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1988

Authors and Affiliations

  • Philip J. Cohen
  • W. Clark Lambert
  • George J. Hill
  • Robert A. Schwartz

There are no affiliations available

Personalised recommendations